NANCY BRODA: Open Payments
NPI 1265625545 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$929 in 40 payments from 22 companies in 2025. Trend: 2023 $409 · 2024 $817 · 2025 $929
Food & beverage: $929
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $192 |
| Phathom Pharmaceuticals, Inc. | 3 | $166 |
| Lilly USA, LLC | 5 | $81 |
| Radius Health, Inc. | 2 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $50 |
| ABBVIE INC. | 2 | $42 |
| Novo Nordisk Inc | 2 | $40 |
| PFIZER INC. | 2 | $38 |
| Ardelyx, Inc. | 2 | $33 |
| Amgen Inc. | 1 | $25 |
Products named: VOQUEZNA, AIRSUPRA, MOUNJARO, FARXIGA, Tymlos, XIFAXAN, Ozempic, NURTEC ODT.
Industry payments across VA — which companies pay providers there.
